System and method for enhanced medicament-based treatment of disease

• US 20070021657A1
• Filed: 04/27/2004
• Published: 01/25/2007
• Est. Priority Date: 05/01/2003
• Status: Abandoned Application

• Current Assignee: Sanofi-Aventis Pharma Limited
• Original Assignee: Aventis Pharma SA (Sanofi )
• Inventors: Galvez, Oscar, Diniz, Marcus
• Application Number:
  US10/555,198
• Publication Number:
  US 20070021657A1
• Time in Patent Office: Days
• US Class Current: 600/300
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/70 for mining of medical data, e.g. analysing previous cases of other patients
• CPC Class Codes: G16H 70/60 relating to pathologies

Abstract

The present invention relates to a method where one acquires and uses data concerning a disease or health dysfunction, providing by way of its processing into useful information an optimized treatment for such a disease or health dysfunction. In another aspect of the invention, the use of such a method leads to an increase in the sales of the medicament for the treatment of such a disease or health dysfunction.

Claims

1. A method for enhancing medicament-based treatment of disease, the method comprising:

receiving from an input source, via a communications network, patient data identifying characteristics of a particular patent;

receiving from the input source, via the communications network, treatment data relating to treatment of the particular patient with a certain medicament for a certain disease;

aggregating said patient data and said treatment data with additional patient data and additional treatment data, respectively, for a plurality of respective patients;

analyzing said aggregated patient data and said aggregated treatment data to identify useful information correlating at least one patient characteristic with a treatment parameter; and

developing a treatment guideline for patients having said at least one patient characteristic based upon said useful information.

2. The method of claim 1, further comprising:

transmitting said treatment guideline via said communication network.

3. The method of claim 1, wherein said patient comprises a human being.

4. The method of claim 1, wherein said disease is diabetes.

5. The method of claim 1, wherein said input source is selected from the group consisting of:

a physician, a nurse, a medicament sales representative, a patient, a patient'"'"'s family member, a potential patient and combinations of two or more thereof.

6. The method of claim 1, further comprising:

remunerating said input source for providing said patient data.

7. The method of claim 1, further comprising:

remunerating said input source for providing said treatment data.

8. The method of claim 1, further comprising:

displaying to said input source, via said communications network, a questionnaire soliciting responses from said input source to gather said patient data and said treatment data.

9. The method of claim 1, wherein said analyzing is performed in an automated fashion.

10. The method of claim 9, wherein said analysis is performed in an automated fashion by computer software employing statistical data analysis techniques.

11. The method of claim 1, wherein said analyzing is performed manually.

12. The method of claim 1, wherein said treatment guideline specifies a certain medicament.

13. The method of claim 1, wherein said treatment guideline specifies a certain medicament intake regimen.

14. The method of claim 1, wherein said treatment guideline specifies instructions to one selected from the group consisting of:

a physician, a nurse, a medicament sales representative, a patient, a patient'"'"'s family member, a potential patient and combinations of two or more thereof.

15. The method of claim 1, further comprising informing an interested party of said useful information.

16. The method of claim 15, further comprising collecting payment from said interested party in exchange for said informing.

17. The method of claim 1, further comprising informing an interested party of said treatment guideline.

18. The method of claim 17, further comprising collecting payment from an interested party in exchange for said informing.

19. The method of claim 1, wherein said analysis is performed by a private institution.

20. The method of claim 1, further comprising advertising in a communications medium an ability to create said treatment guideline.

21. The method of claim 1, further comprising advertising availability of said treatment guideline for treatment of said disease using said medicament.

22. The method of claim 1, wherein said medicament is capable of providing a slow release of insulin in the treatment of diabetes in a living being.

23. A method for enhancing medicament-based treatment of disease, the method comprising:

receiving from an input source, via a communications network, patient data identifying characteristics of a particular patient;

receiving from the input source, via the communications network, treatment data relating to treatment of the particular patient with a certain medicament for a certain disease;

aggregating said patient data and said treatment data with additional patient data and additional treatment data, respectively, for a plurality of respective patients;

analyzing said aggregated patient data and said aggregated treatment data; and

identifying a statistically significant correlation between at least one patient characteristic and a treatment parameter.

24. A method for enhancing medicament-based treatment of disease, the method comprising:

receiving from an input source, via a communications network, patient data identifying characteristics of a particular patient;

receiving from the input source, via the communications network, treatment data relating to treatment of the particular patient with a certain medicament for a certain disease;

aggregating said patient data and said treatment data with additional patient data and additional treatment data, respectively, for a plurality of respective patients;

analyzing said aggregated patient data and said aggregated treatment data; and

identifying a statistically significant correlation between at least one patient characteristic and an effectiveness of said medicament for treating said disease.

25. The method of claim 24, further comprising initiating medical research to investigate said correlation.